TherapeuticsMD (TXMD) Non Operating Income (2009 - 2026)
TherapeuticsMD (TXMD) reported Non Operating Income of $980,000 for Q2 2026, down 21.0% from $1.24 million a year earlier but up 18.6% from the prior quarter.
Powered by 
Analysis
TherapeuticsMD (TXMD) Non Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, TherapeuticsMD's Non Operating Income came in at $3.69 million, up 17.0% year-over-year; for FY2025, it came in at $3.74 million, down 0.8% from FY2024.
- By year, Non Operating Income came in at $3.77 million in FY2024 (+382.6%), $781,000 in FY2023, -$117,000 in FY2022 and $272,000 in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$22.79 million in Q1 2022 and a high of $25.35 million in Q4 2021.
- Year over year, Non Operating Income gained in five of the last seven quarters, with growth averaging 32.8%.
- The high point for year-over-year Non Operating Income in five years was Q4 2023 (growth of 145.5%); the low point was Q4 2022 (a decline of 100.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $826,000 (Q1 2026), $972,000 (Q4 2025) and $912,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | -202.00 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 1.63 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -130.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | TherapeuticsMD | 20.14 Mn | -12.07 Mn | - | 980,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 980,000.00 |
| Mar 31, 2026 | 826,000.00 |
| Dec 31, 2025 | 972,000.00 |
| Sep 30, 2025 | 912,000.00 |
| Jun 30, 2025 | 1.24 Mn |
| Mar 31, 2025 | 613,000.00 |
| Dec 31, 2024 | 735,000.00 |
| Sep 30, 2024 | 567,000.00 |
| Jun 30, 2024 | 1.74 Mn |
| Mar 31, 2024 | 333,000.00 |
| Dec 31, 2023 | 27,000.00 |
| Sep 30, 2023 | 339,000.00 |
| Jun 30, 2023 | 58,000.00 |
| Mar 31, 2023 | 357,000.00 |
| Dec 31, 2022 | 11,000.00 |
| Sep 30, 2022 | -112,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -22.79 Mn |
| Dec 31, 2021 | 25.35 Mn |
| Sep 30, 2021 | -7.50 Mn |
API Access
TherapeuticsMD Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=TXMD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "TXMD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=TXMD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();